0001213900-23-044093.txt : 20230530
0001213900-23-044093.hdr.sgml : 20230530
20230530171046
ACCESSION NUMBER: 0001213900-23-044093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230525
FILED AS OF DATE: 20230530
DATE AS OF CHANGE: 20230530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TRAVERSA SERGIO
CENTRAL INDEX KEY: 0001565832
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39082
FILM NUMBER: 23977620
MAIL ADDRESS:
STREET 1: 138 CANTERBURY LN
CITY: BLUE BELL
STATE: PA
ZIP: 19422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001553643
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455401931
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: 646 876 3459
MAIL ADDRESS:
STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CAMP NINE, INC.
DATE OF NAME CHANGE: 20120706
4
1
ownership.xml
X0407
4
2023-05-25
0
0001553643
RELMADA THERAPEUTICS, INC.
RLMD
0001565832
TRAVERSA SERGIO
C/O RELMADA THERAPEUTICS, INC.
2222 PONCE DE LEON BLVD, 3RD FLOOR
CORAL GABLES
FL
33134
1
1
0
0
Chief Executive Officer
0
Stock Option (right to buy)
3.37
2023-05-25
4
A
0
527211
0
A
2022-12-16
2032-12-16
Common Stock
527211
850728
D
The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders.
80,728 of the options immediately vested; 770,000 options vest in 16 equal quarterly installments commencing on March 16, 2023.
/s/ Sergio Traversa
2023-05-30